Concepedia

Nicholas C. Kallan

NC

10

Publications

520

Citations

10

H-Index

2000

Active since

Affiliations

Array BioPharma (United States)(Current)

Nicholas C. Kallan is an author at Array BioPharma (United States) specializing in medicine, drug discovery, and medicinal chemistry.

Top concepts

Publications per year

2000–2014

10

Publications

10

Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors

James F. Blake, Rui Xu, Josef R. Bencsik et al. · Journal of Medicinal Chemistry · 2012 · 184 citations · Full text

, , +15

Synthesis of the Ring System of Phomactin D Using a Suzuki Macrocyclization

Nicholas C. Kallan, Randall L. Halcomb · Organic Letters · 2000 · 80 citations

Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species

Kevin W. Hunt, Adam W. Cook, Ryan J. Watts et al. · Journal of Medicinal Chemistry · 2013 · 58 citations · Full text

A potential therapeutic target for FLT3-ITD AML: PIM1 kinase

Amir T. Fathi, Omotayo Arowojolu, Ian Swinnen et al. · Leukemia Research · 2011 · 56 citations · Full text

, , +6

Discovery and SAR of spirochromane Akt inhibitors

Nicholas C. Kallan, Keith L. Spencer, James F. Blake et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 42 citations · Full text

, , +6

Rows per page

1–5 of 10